FOOD AND DRUG ADMINISTRATION 
Center for Drug Evaluation and Research 

 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FDA White Oak Campus, Building 31, The Great Room (Rm. 1503) 

White Oak Conference Center, Silver Spring, Maryland 

March 28 - 29, 2012 

MEETING ROSTER 

 

 

David M. Capuzzi, M.D., Ph.D. 
Professor of Medicine and Biochemistry 
Thomas Jefferson University & 
Lankenau Institute for Medical Research 
Philadelphia, Pennsylvania 
 

 
DESIGNATED FEDERAL OFFICER (Non-Voting)  
 
Paul T. Tran, R.Ph  
Division of Advisory Committee and Consultant Management  
Office of Executive Programs, CDER, FDA 
 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBERS 
(Voting) 
                                                                                                  
Erica H. Brittain, Ph.D. 
Mathematical Statistician  
Biostatistics Research Branch 
National Institute of Allergy and Infectious Diseases 
(NIAID), National Institutes of Health (NIH) 
Bethesda, Maryland 
 
Eric I. Felner, M.D., MSCR 
Associate Professor of Pediatrics 
Division of Pediatric Endocrinology 
Director, Pediatric Endocrinology Fellowship 
Program 
Emory University School of Medicine 
Atlanta, Georgia 
 
Ellen W. Seely, M.D. 
Professor of Medicine 
Harvard Medical School 
Director of Clinical Research 
Endocrinology, Diabetes and Hypertension Division 
Vice Chair for Faculty Development 
Department of Medicine 
Brigham & Women's Hospital 
Boston, Massachusetts 
 
Abraham Thomas, M.D., M.P.H., FACP 
(Chairperson) 
Division Head, Endocrinology, Diabetes, Bone, and 
Mineral Disorders 
Henry Ford Hospital 
Whitehouse Chair of Endocrinology 
Detroit, Michigan  
 

Lamont G. Weide, M.D., Ph.D., FACE 
Chief, Diabetes & Endocrinology 
Professor, Internal Medicine  
University of Missouri - Kansas City 
Truman Medical Centers, Diabetes Center 
Kansas City, Missouri 

Ida L. Spruill, Ph.D., R.N. 
(Consumer Representative) 
Assistant Professor, College of Nursing 
Medical University of South Carolina 
Charleston, South Carolina 
 

Edward W. Gregg, Ph.D. 
Chief, Epidemiology and Statistics Branch 
Division of Diabetes Translation 
Centers for Disease Control and Prevention (CDC) 
Atlanta, Georgia  
 

Page 1 of 4 

FOOD AND DRUG ADMINISTRATION 
Center for Drug Evaluation and Research 

 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FDA White Oak Campus, Building 31, The Great Room (Rm. 1503) 

White Oak Conference Center, Silver Spring, Maryland 

March 28 - 29, 2012 

 

MEETING ROSTER (cont.) 

 

 
 
ACTING INDUSTRY REPRESENTATIVE TO THE COMMITTEE (Non-Voting) 
 
Mads F. Rasmussen, M.D., Ph.D. 
(Acting Industry Representative) 
Executive Director 
Diabetes - Clinical Development and Research 
Clinical Development, Medical and Regulatory 
Affairs 
Novo Nordisk Inc.  
Princeton, New Jersey 
 
TEMPORARY MEMBERS (Voting) 
 
John H. Alexander, M.D., M.H.S. 
Associate Professor of Cardiology/Medicine 
Duke Clinical Research Institute 
Duke University Medical Center 
Durham, North Carolina 
 
William O. Cooper, M.D., M.P.H. 
Professor and Vice Chair for Faculty Affairs 
Department of Pediatrics 
Vanderbilt University 
Nashville, Tennessee 
 
Ed J. Hendricks, M.D. 
Medical Director  
Center for Weight Management  
Roseville and Sacramento, California 
 

Richard N. Bergman, Ph.D. 
The Alfred Jay Firestein Chair in Diabetes Research 
Director, Cedars-Sinai Diabetes and Obesity Research 
Institute 
Los Angeles, California 
 
Allison B. Goldfine, M.D. 
Assistant Director of Clinical Research 
Joslin Diabetes Center, Research Division 
Boston, Massachusetts 

Michael D. Jensen, M.D.  
Tomas J. Watson, Jr. Professor in Honor of  
Dr. Robert L. Frye 
Endocrine Research Unit  
Mayo Clinic  
Rochester, Minnesota 
 

William R. Hiatt, M.D., FACP 
Professor of Medicine  
Division of Cardiology 
University of Colorado School of Medicine  
President, Colorado Prevention Center  (CPC) Clinical 
Research 
Aurora, Colorado 
 
Sanjay Kaul, M.D. 
Director, Fellowship Training Program in 
Cardiovascular Diseases 
Cedars-Sinai Heart Institute 
Professor, David Geffen School of Medicine at UCLA 
Division of Cardiology 
Cedar Sinai Medical Center  
Los Angeles, California 
 

Page 2 of 4 

FOOD AND DRUG ADMINISTRATION 
Center for Drug Evaluation and Research 

 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FDA White Oak Campus, Building 31, The Great Room (Rm. 1503) 

White Oak Conference Center, Silver Spring, Maryland 

March 28 - 29, 2012 

MEETING ROSTER (cont.) 

 

 
TEMPORARY MEMBERS (Voting) 
 
Marvin A. Konstam, M.D. 
Chief Physician Executive  
The CardioVascular Center 
Tufts Medical Center 
Professor of Medicine 
Tufts University School of Medicine 
Boston, Massachusetts 
 
Lynn McAfee (Patient Representative) 
North Port, Florida 
 

Peter J. Savage, M.D.   
Senior Advisor to the Director 
Division of Diabetes, Endocrinology & Metabolic 
Diseases (DDEMD) 
National Institute of Diabetes and Digestive 
and Kidney Diseases (NIDDK), NIH 
Bethesda, Maryland 
 
Jack A. Yanovski, M.D., Ph.D. 
Chief, Section on Growth and Obesity 
Program in Developmental Endocrinology and 
Genetics (PDEGEN) 
Eunice Kennedy Shriver National Institute of 
Child Health and Human Development (NICHD) 
NIH 
Bethesda, Maryland 
 
SPEAKER (Non-Voting) 
 
William C. Knowler, M.D., Dr.PH 
Chief, Diabetes Epidemiology and  
Clinical Research Section 
NIDDK, NIH 
Phoenix, Arizona 
 

Judith M. Kramer, M.D., M.S. 
Associate Professor of Medicine 
Duke University Medical Center 
Executive Director, Clinical Trials Transformation 
Initiative (CTTI) 
Duke Translational Medicine Institute 
Durham, North Carolina 

Michael A. Proschan, Ph.D. 
Mathematical Statistician  
Biostatistics Research Branch 
NIAID, NIH 
Bethesda, Maryland 
 
David D. Waters, M.D. 
Emeritus Professor  
Department of Medicine  
University of California, San Francisco 
San Francisco, California 

 

 

 
 

Page 3 of 4 

FOOD AND DRUG ADMINISTRATION 
Center for Drug Evaluation and Research 

 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

FDA White Oak Campus, Building 31, The Great Room (Rm. 1503) 

White Oak Conference Center, Silver Spring, Maryland 

March 28 - 29, 2012 

MEETING ROSTER (cont.) 

 

 
GUEST SPEAKERS (Non-Voting) 
 
George A. Bray, M.D., MACP, MACP 
Boyd Professor 
Chief, Division of Clinical Obesity & Metabolism 
Pennington Biomedical Research Center 
Louisiana State University 
Baton Rouge, Louisiana 

Rena R. Wing, Ph.D. 
Professor of Psychiatry & Human Behavior 
Warren Alpert Medical School of Brown 
University 
Director, Weight Control & Diabetes Research 
Center 
The Miriam Hospital 
Providence, Rhode Island 
 
FDA PARTICIPANTS (Non-Voting) 
 
Robert J. Temple, M.D. 
Deputy Center Director for Clinical Science 
Immediate Office of the Director 
CDER, FDA 
 
Mary H. Parks, M.D. 
Director  
Division of Metabolism and Endocrinology 
Products (DMEP) 
ODE II, OND, CDER, FDA 
 
Solomon Iyasu, M.D., M.P.H. 
Director 
Division of Epidemiology I 
Office of Pharmacovigilance and Epidemiology 
Office of Surveillance and Epidemiology (OSE) 
CDER, FDA 
 

Robert H. Eckel, M.D. 
Professor of Medicine 
Division of Endocrinology, Metabolism and Diabetes 
Division of Cardiology 
Professor of Physiology and Biophysics 
Charles A. Boettcher II Chair in Atherosclerosis 
University of Colorado Anschutz Medical Campus 
Aurora, Colorado 
 
 

 
 
Curtis J. Rosebraugh, M.D., M.P.H. 
Director 
Office of Drug Evaluation (ODE) II 
Office of New Drugs (OND), CDER, FDA 
 
Eric C. Colman, M.D. 
Deputy Director 
DMEP, ODE II, OND, CDER, FDA 
 

 

Page 4 of 4 

